Heron Therapeutics Inc. buy Rodman & Renshaw
Start price
13.06.24
/
50%
€3.38
Target price
13.06.25
€6.48
Performance (%)
-43.68%
Price
02.10.24
€1.91
Summary
This prediction is currently active. The BUY prediction by Rodman___Renshaw for Heron Therapeutics Inc. is performing very badly with a performance of -43.68%. This prediction currently runs until 13.06.25. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Heron Therapeutics Inc. | 3.643% | 3.643% |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Rodman___Renshaw for this prediction
In the thread Heron Therapeutics Inc. diskutieren
Heron Therapeutics, Inc. (NASDAQ: HRTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
Ratings data for HRTX provided by MarketBeat